How did LifeMD's telehealth revenue surge in Q4 2024?

LifeMD's telehealth revenue surged in Q4 2024 due to several key factors:

1. **Successful Uptake of Virtual Programs**: The company's virtual "GLP-1 Weight Management" program, which provides access to both branded and compounded GLP-1 drugs for obesity patients, has been a significant growth driver. This program contributed to the substantial increase in revenue within its core Telehealth segment.
2. **Increase in Patient Subscribers**: LifeMD expanded its service reach by launching a new National Pharmacy in Pennsylvania, thereby catering to nearly 270,000 patient subscribers. This expansion likely led to higher patient engagement and revenue generation.
3. **Growth in Weight Management Programs**: Mizuho's analysis suggests that over half of LifeMD's revenue will stem from Weight Management programs by 2026, up from 0% in 2022. This indicates a growing reliance on specialized services, which are likely contributing to the revenue surge.

In summary, LifeMD's telehealth revenue surge in Q4 2024 can be attributed to the successful implementation of virtual programs, increase in patient subscribers, and growth in Weight Management programs. These factors collectively propelled a significant rise in the company's quarterly revenue.